Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter Ultracentrifuges to Include Aviv Fluorescent Detection System

NEW YORK (GenomeWeb News) – Beckman Coulter announced yesterday that Aviv Biomedical would sell and install its Fluorescence Detection System on Beckman Coulter’s ProteomeLab XL-A, XL-I analytical centrifuges currently in the field.
 
Beckman’s ProteomeLab instruments measure proteins and other macromolecules as interacting elements in solution instead of in isolation, diluted, or bound to a substrate.
 
The Fullerton, Calif.-based firm said that Aviv’s FDS offers a “complementary approach to measuring molecular interaction and aggregation behavior.” Using fluorescent labeling, the system enables researchers to validate lead drug efficacy by confirming that it binds only to a desired substrate and to other components, said Beckman.
 
While Lakewood, NJ-based Aviv will sell and install the FDS, Beckman said that it would validate the installation.
 
Financial and other terms of the alliance were not announced.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.